3. Tiềm năng của MSCs trong điều trị bệnh lý tim mạch
The therapeutic potential of mesenchymal stem cells for cardiovascular diseases
Guo et al. Cell Death and Disease (2020) 11:349
https://doi.org/10.1038/s41419-020-2542-9
Cell Death & Disease
REVIEW ARTICLE | Open Access
The therapeutic potential of mesenchymal stem cells for cardiovascular diseases
Yajun Guo1,2 | Yunsheng Yu1,2 | Shijun Hu1,2,3,4 | Yueqiu Chen1,2 | Zhenya Shen1,2
Mesenchymal stem cell transplantation after acute myocardial infarction: a meta-analysis of clinical trials
Attar et al. Stem Cell Research & Therapy (2021) 12:600
https://doi.org/10.1186/s13287-021-02667-1
RESEARCH | Open Access
Mesenchymal stem cell transplantation after acute myocardial infarction: a meta-analysis of clinical trials
Armin Attar1* | Fateme Bahmanzadegan Jahromi2 | Shahin Kavousi2 | Ahmad Monabati3,4 | Asma Kazemi5*
Mesenchymal Stem Cell Immunomodulation: A Novel Intervention Mechanism in Cardiovascular Disease
REVIEW
published: 12 January 2022
doi: 10.3389/fcell.2021.742088
Mesenchymal Stem Cell Immunomodulation: A Novel Intervention Mechanism in Cardiovascular Disease
Yueyao Wang1,2† | Zhongwen Qi 3† | Zhipeng Yan1 | Nan Ji 1 | Xiaoya Yang1 | Dongjie Gao1 | Leilei Hu1 | Hao Lv 1 | Junping Zhang1* | Meng Li 1
Improvement in Left Ventricular Function with Intracoronary Mesenchymal Stem Cell Therapy in a Patient with Anterior Wall ST-Segment Elevation Myocardial Infarction
Cardiovascular Drugs and Therapy (2018) 32:329–338
https://doi.org/10.1007/s10557-018-6804-z
ORIGINAL ARTICLE
Improvement in Left Ventricular Function with Intracoronary Mesenchymal Stem Cell Therapy in a Patient with Anterior Wall ST-Segment Elevation Myocardial Infarction
Su Hyun Kim1 & Jang Hyun Cho1 & Yoon Ho Lee 2 & Ji Hye Lee2 & Soo Sung Kim2 & Mi Yang Kim2 & Min Gu Lee1 & Won Yu Kang1 & Kyung Sim Lee3 & Young Keun Ahn4 & Myung Ho Jeong4 & Hyun Soo Kim5
Published online: 28 June 2018
© The Author(s) 2018
A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial†
European Heart Journal (2016) 37, 256–263
doi:10.1093/eurheartj/ehv493
CLINICAL RESEARCH
Acute coronary syndromes
A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial†
Fizzah Choudry1‡, Stephen Hamshere1‡, Natalie Saunders2, Jessry Veerapen1, Katrine Bavnbek3, Charles Knight1, Denis Pellerin3, Didier Locca4, Mark Westwood1, Roby Rakhit5, Tom Crake3, Jens Kastrup6, Mahesh Parmar7, Samir Agrawal2, Daniel Jones1, John Martin8, and Anthony Mathur1,9*
Tiềm năng của tế bào gốc trung mô trong điều trị bệnh lý tim mạch
Tiềm năng của tế bào gốc trung mô trong điều trị bệnh lý tim mạch
The therapeutic potential of mesenchymal stem cells for cardiovascular diseases (2020)
Mesenchymal Stem Cell Immunomodulation: A Novel Intervention Mechanism in Cardiovascular Disease (2021)
Mesenchymal stem cell transplantation after acute myocardial infarction: a meta-analysis of clinical trials (2021)